Читать книгу Social Capital in the University-Based Innovation Ecosystems in the Leading Life-Science Clusters: Implications for Poland - Małgorzata Runiewicz-Wardyn - Страница 12
List of figures
ОглавлениеFigure 1.1. Social network without and with “closure”
Figure 1.2. The role of social capital in Triple Helix networks
Figure 1.3. Role of intermediaries in the Triple Helix networks
Figure 2.1. Technological change and technological convergence in the life sciences industry
Figure 2.2. Technological convergence and multidisciplinary approach in the life sciences
Figure 2.3. Product innovation life cycle in the biopharmaceutical sector
Figure 3.1. Patent registrations for new medicines by region, in thousands, 2005–2018
Figure 3.2. European biotechnology financing by year, 2001–2016
Figure 3.3. Innovation capital raised by leading European countries, 2016
Figure 3.4. US life sciences venture capital funding
Figure 3.5. Innovation capital raised by leading US regions, 2016
Figure 3.6. Clinical trials initiated in Europe, the United States and other countries during 2014–2019, per one million inhabitants
Figure 4.1. The growing rank of the University of Cambridge in the life sciences sector, 2011–2019
Figure 4.2. Cambridge University’s overall scores in the categories Life Sciences, and Clinical, Pre-clinical & Health
Figure 5.1. The growing rank of the University of Copenhagen in the biological sciences, 2011–2019/2020
Figure 5.2. The University of Copenhagen’s overall scores in the categories Life Sciences, and Clinical, Pre-clinical & Health, 2019
Figure 5.4. Lund University’s overall scores in the categories Life Sciences, and Clinical, Pre-clinical & Health, 2019
Figure 6.1. The rank of Stanford University (a) and the University of California, Berkeley (b), in the life sciences sector, 2011–2020
Figure 6.2. The overall scores of Stanford University (a) and the University of California, Berkeley (b), in the categories: Life Sciences and Clinical, Pre-clinical & Health
Figure 7.1. The growing rank of the University of Washington in the life sciences sector, 2011–2019
Figure 7.2. The overall scores of the University of Washington in the Life Sciences category and the Clinical, Pre-clinical & Health category, 2019
Figure 8.1. Number of clinical trials in Poland, 2003–2017
Figure 8.2(a). The Jagiellonian University’s overall scores in the life sciences and the category Clinical, Pre-clinical & Health, 2019
Figure 8.2(b). Warsaw University’s and Adam Mickiewicz University’s overall scores in the life sciences ranks, 2019
Figure 8.3. Patent applications and patents granted by the Jagiellonian University, 2007–2019
Figure 8.4. Patent applications and patents granted by University of Warsaw in 2007–2019